Portefeuille de produits de FMG Pharma
Advancing investigational therapeutic candidates for metabolic, cardiometabolic and dermatologic disease.
Development Programs
Pipeline at a Glance
FMG is advancing a focused portfolio of investigational candidates across metabolic, cardiometabolic and dermatologic disease.
Metabolic dysfunction-associated steatotic liver disease
MASLD / MASH
Cutaneous complications of diabetes
Diabetic dermatology / wound healing
Dyslipidémie et maladies cardiométaboliques
Cardiometabolic disease
Pipeline status as of August 2026.
Work With FMG
Partnering & Collaboration
FMG welcomes discussions with pharmaceutical, biotechnology and research organizations interested in our development programs and related opportunities for collaboration.
Contact FMG